Loading…

Abstract 13006: Digital Diabetes Prevention Program Reduces Medical Costs in the First 2 Years of Implementation in a Workplace Setting

IntroductionThe Diabetes Prevention Program (DPP) was shown to reduce body weight and lower incidence of diabetes in a cost-effective manner. Digital versions of the DPP (dDPP) have recently been implemented and shown to reduce body weight and other risk factors for chronic disease. We asked whether...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13006-A13006
Main Authors: Birse, Charles E, Iakoubova, Olga A, Arellano, Andre R, Fragala, Maren S, Bare, Lance A, Castro Sweet, Cynthia M, Lagier, Robert J
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionThe Diabetes Prevention Program (DPP) was shown to reduce body weight and lower incidence of diabetes in a cost-effective manner. Digital versions of the DPP (dDPP) have recently been implemented and shown to reduce body weight and other risk factors for chronic disease. We asked whether implementation of a dDPP in a workplace setting would reduce medical costs. MethodsEmployees and spouses of a nation-wide medical diagnostic provider were eligible to participate in dDPP (Omada Health) if they had prediabetes (fasting glucose 100 to 125 mg/dL or HbA1C 5.7% to 6.4%) and BMI ≥25 kg/m2 at baseline (September to December 2017), and were continuously enrolled in a health plan from September 2016 to December 2019. Of those eligible (n=3,098), 432 participated and completed ≥1 lesson (dDPP group). A control group (n=856) was matched to the dDPP group by baseline age, sex, race, geography, comorbidities, health plan type, and medical and prescription costs. Generalized estimating equations adjusted for age, race and BMI were used to obtain all estimates. Allowed costs from administrative claims data were evaluated per member per month (PMPM); dDPP costs were not included. ResultsIn the control group, costs were higher in the post-dDPP period (2017-2019) compared to the pre-dDPP period (2016-2017) for inpatient ($124 vs $64, P=0.01), prescription ($183 vs $155, P=0.02), and total ($696 vs $558, P
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.142.suppl_3.13006